Bladder Cancer

Culture of Bladder Cancer Organoids as Precision Medicine Tools - Beyond the Abstract May 3, 2022

Immune Checkpoints Inhibitors in the Management of High-Risk Non-Muscle-Invasive Bladder Cancer. A Scoping Review - Beyond the Abstract April 27, 2022

Diagnostic Accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) in Suspected Muscle Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis - Beyond the Abstract April 26, 2022

Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study - Beyond the Abstract April 20, 2022

Predictive Factors of Early Postoperative Complications After Robot-Assisted Radical Cystectomy for Urothelial Bladder Carcinoma - Beyond the Abstract April 13, 2022

Female Sexual Function Following Radical Cystectomy in Bladder Cancer - Beyond the Abstract April 13, 2022

Gene Network Profiling in Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract April 4, 2022

Urinary Microbiota and Urological Tumors: Where Are We Heading? - Beyond the Abstract April 4, 2022

Genomic Features of Muscle-invasive Bladder Cancer Arising after Prostate Radiotherapy - Beyond the Abstract March 30, 2022

Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database - Beyond the Abstract March 25, 2022

Bladder Cancer in a Population-Based Cohort from Stockholm County with Long-Term Follow-Up; a Comparative Analysis of Prediction Models for Recurrence and Progression, Including External Validation of the Updated 2021 EAU Model - Beyond the Abstract March 23, 2022

Bladder-Sparing Combination Treatments for Muscle-Invasive Bladder Cancer: A Plea for Standardized Assessment and Definition of Clinical Trials Endpoints - Beyond the Abstract March 15, 2022

Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin - Beyond the Abstract March 8, 2022

Long Term Cost Comparisons of Radical Cystectomy versus Trimodal Therapy for Muscle-Invasive Bladder Cancer - Beyond the Abstract March 7, 2022

Development of a Multiplex Immuno-Oncology Biomarker and Digital Pathology Workflow for Assessment of Urothelial Carcinoma - Beyond the Abstract February 1, 2022

Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin - Beyond the Abstract January 19, 2022

Oncofid-P-B for High Risk NMIBC: Do We Really Need a Phase III? Yes, We Do - Beyond the Abstract January 18, 2022

Analysis of Open Chromatin Regions in Bladder Cancer Links β-Catenin Mutations and Wnt Signaling with Neuronal Subtype of Bladder Cancer - Beyond the Abstract January 10, 2022

Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States - Beyond the Abstract November 15, 2021

Utility of Stromal Tumor Infiltrating Lymphocyte Scoring (sTILs) for Risk Stratification of Patients with Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy - Beyond the Abstract November 9, 2021

Page 1 of 19

email news signup